Ten carbapenem-resistant Enterobacteriaceae (eight Klebsiella pneumoniae isolates and two Enterobacter cloacae) isolates from Yemen were investigated using in vitro antimicrobial susceptibility testing, phenotypic carbapenemase detection, multilocus sequence typing (MLST) and replicon typing. Carbapenemase, extended-spectrum b-lactamase (ESBL) and plasmidmediated quinolone resistance determinant genes were identified using PCR and sequencing. All of the 10 carbapenem-resistant Enterobacteriaceae were resistant to b-lactams, tobramycin, ciprofloxacin and cotrimoxazole. Imipenem, doripenem and meropenem MICs ranged from 2 to .32 mg l "1 and ertapenem MICs ranged from 6 to .32 mg l "1
INTRODUCTION
The emergence and spread of antimicrobial resistance conferred by the production of b-lactamases among Gramnegative bacteria are a serious problem in the hospital environment as well as in the community. Due to the emergence of resistance by extended-spectrum b-lactamases (ESBLs), carbapenems are often used for the treatment of infections caused by Gram-negative bacteria. However, extensive use of carbapenems is probably the most significant reason for the increasing resistance to this class of b-lactams by production of carbapenemases (Nordmann et al., 2011) .
Ambler class A (mostly bla KPC ), class B [metallo-blactamases (MBLs); mostly bla VIM and bla NDM and, to a lesser extent, bla IMP ] and class D (oxacillinases; mostly bla ) are the major carbapenemases reported worldwide in Enterobacteriaceae (Nordmann et al., 2011) .
MBL expression in Gram-negative bacteria confers resistance to penicillins, cephalosporins and carbapenems. MBLs are not inhibited by the presence of commercially available b-lactamase inhibitors, and susceptibility to monobactams appears to be preserved in the absence of concomitant expression of other resistance mechanisms, such as ESBL production (Patel & Bonomo, 2013) .
NDM-1 was first identified in 2008 in Sweden in a patient previously hospitalized in India. The patient was colonized with one Klebsiella pneumoniae strain and one Escherichia coli strain carrying bla NDM-1 on transferable plasmids. NDM-1 confers resistance to all b-lactams (including carbapenems) except aztreonam (Yong et al., 2009 ). To date, 11 minor variants of NDM-1 (NDM-2 to NDM-12) have been identified (http://www.lahey.org/studies/).
Since the first description in 2008, NDM-1-producing organisms have been reported in hospitalized patients in Europe, Australia and North America, and in patients returning from South Asian countries, especially India and Pakistan (Kumarasamy et al., 2010) . International travel and the use of multiple healthcare systems have contributed to the rapid spread of bla NDM-1 , with potentially serious consequences (Muir & Weinbren, 2010) .
In the Arabian Peninsula, NDM-1 has been reported in Oman, the United Arab Emirates, Kuwait, Saudi Arabia and Qatar (Poirel et al., 2011a; Ghazawi et al., 2012; Jamal et al., 2012; Al-Agamy et al., 2013; Shibl et al., 2013; Zowawi et al., 2014) but not in Yemen. Here, to the best of our knowledge, we describe the first NDM-producing Enterobacteriaceae strains isolated in Yemen.
METHODS
Bacterial isolates. During February 2013, eight K. pneumoniae isolates and two Enterobacter cloacae isolates with a reduced susceptibility to carbapenems were collected in Al-Thawra Hospital, Saudi German Hospital and the Ailaqi private medical laboratory in Sana'a, Yemen. They were identified using the API 20E identification system (bioMérieux) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (IVD MALDI Biotyper; Bruker Biospin SAS).
Escherichia coli ATCC 25922 was used for quality control. Azideresistant Escherichia coli J53 was used as the recipient strain in conjugation experiments and Escherichia coli ElectroMAX DH10B competent cells (Invitrogen) for electrotransformation.
The following carbapenemase-producing isolates were used as PCR controls and were kindly provided by P. Courvalin (Antibacterial Agents Unit Institut Pasteur Paris, France; U2A2730: Escherichia coli OXA-48; U2A1977: K. pneumoniae NDM-1; U2A2242: Enterobacter cloacae KPC, U2A2257; Pseudomonas aeruginosa IMP-1; U2A2016: K. pneumoniae VIM), R. Bonnet (Laboratoire de Bactériologie CHRU Clermont-Ferrand, France; Proteus mirabilis OXA-23, Acinetobacter baumannii OXA-24) and L. Poirel (Service de Bactériologie-Virologie CHU Bicêtre, Le Kremlin-Bicêtre, France; A. baumannii OXA-58).
The following cephalosporinase-producing isolates were used as PCR controls and were kindly provided by G. Arlet (KP SLK54: K. pneumoniae ACC-1; KP760: K. pneumoniae DHA-1; KOL: K. pneumoniae MOX-2; 96D: K. pneumoniae MIR-1; Bhe CD93: K. pneumoniae CMY-4; 1731: Klebsiella oxytoca FOX-3).
Antimicrobial susceptibility testing. Antibiotic susceptibility was determined on Mueller-Hinton agar using the standard diskdiffusion procedure as described by the European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2014) (CLSI, 2012) and MBL production was screened with an MBL Etest (bioMérieux).
In addition, a double-disc synergy test was used for detecting MBLs, as described previously (Yong et al., 2002) .
Detection of antibiotic resistance genes. Carbapenemase-encoding genes bla KPC , bla VIM , bla IMP , bla NDM , bla OXA-23-like , bla OXA-24-like , bla OXA-58-like and bla OXA-48-like were screened using multiplex PCRs (Table 1) . Amplicon sizes were, respectively, 86, 254, 238, 187, 146, 120, 166 and 214 bp. PCR was performed in 50 ml reaction mixtures containing 2.5 U Taq DNA polymerase (Qiagen), 2 mM MgCl 2 and 0.25 mM each primer. The following cycling parameters were used: initial denaturation at 95 uC for 3 min, then 35 cycles of denaturation at 94 uC 40 s, annealing at 55 uC for 30 s and extension at 72 uC for 20 s, with a final extension at 72 uC for 10 min.
Plasmid-mediated AmpC-type genes bla ACC , bla FOX , bla MOX , bla DHA , bla CMY and bla MIR were screened using multiplex PCRs (Table 1) . Amplicons sizes were, respectively, 232, 327, 507, 459, 613 and 142 bp. PCR was performed in the same conditions as for carbapenemase genes multiplex PCR.
ESBL gene detection (bla TEM , bla SHV , bla CTX-M and bla GES ) was screened with PCR as described previously (Poirel et al., 2000; Kermas et al., 2012) (Table 1) .
Screening of qnrA, qnrB, qnrS, qnrC, qnrD and qepA genes was carried out with a multiplex real-time PCR assay as described previously (Guillard et al., 2011) . Pyrosequencing was used for detection of the aac(69)-Ib-cr determinant (Guillard et al., 2010) .
All PCR products were sequenced, and the sequencing results were compared with reported sequences available in GenBank.
Multilocus sequence typing (MLST). MLST was performed on the K. pneumoniae isolates using seven conserved housekeeping genes (gapA, infB, mdh, pgi, phoE, rpoB and tonB) (Diancourt et al., 2005) . A detailed protocol of the MLST procedure, including allelic type and sequence type (ST) assignment methods, is available in MLST databases from the Pasteur Institute, Paris, France (http://www. pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html).
Transfer of the carbapenem resistance determinant by conjugation. Azide-resistant Escherichia coli J53 was used as the recipient strain for broth and filter mating assays (Guillard et al., 2014) . Transconjugants were selected using a brain-heart infusion (BHI) agar plate supplemented with 1 mg ertapenem ml 21 and 100 mg sodium azide ml 21 .
When the resistance plasmid transfer failed in mating experiments, transformation was used. Plasmid DNA was isolated using a QIAprep Spin Miniprep kit (Qiagen) according to the manufacturer's protocol. Escherichia coli ElectroMAX DH10B competent cells (Invitrogen) were transformed with plasmid DNA by electroporation (MicroPulser electroporator; Bio-Rad Laboratories) according to the manufacturer's instructions. Transformants were selected on BHI agar containing 1 mg ertapenem ml 21 .
RESULTS

Detection of NDM-1-producing isolates and antibiotic susceptibility
During February 2013, 10 Enterobacteriaceae isolates (eight K. pneumoniae and two Enterobacter cloacae isolates) from 10 patients with a reduced susceptibility to carbapenems (tested by the disk-diffusion technique) were included in this study. Specimen sources were urine (n53), pus (n53), blood (n51), sputum (n51), vagina (n51) and ascites fluid (n51). The clinical characteristics of the 10 patients are shown in Table 2 .
With disc susceptibility testing, all the Enterobacteriaceae isolates were resistant or intermediate to b-lactams (including carbapenems, extended-spectrum cephalosporins, penicillins and aztreonam), tobramycin, ciprofloxacin and cotrimoxazole. In vitro susceptibility was found for tigecycline (100 %), fosfomycin (90 %), chloramphenicol (60 %), imipenem (40 %), tetracycline (30 %) and amikacin (20 %).
Imipenem, doripenem and meropenem MICs ranged from 2 to .32 mg l 21 and ertapenem MICs ranged from 6 to .32 mg l 21 for the 10 isolates (Table 2) .
A modified Hodge test, MBL Etest and imipenem-EDTA synergy test were positive for the 10 isolates. All K. pneumoniae isolates showed ESBL activity in phenotypic tests.
PCR detection of resistance genes
PCR detected the presence of bla NDM genes in all strains. In addition, all K. pneumoniae strains produced CTX-M-15 ESBL, and TEM-1 b-lactamase was detected in seven strains: one Enterobacter cloacae and six K. pneumoniae isolates ( Table 2 ). All K. pneumoniae isolates expressed SHV b-lactamases: SHV-1 (two isolates), SHV-11 (four Table 2 ). In addition, six isolates produced AAC-69-Ib-cr and four isolates produced AAC-69-Ib.
MLST
MLST analysis of the eight K. pneumoniae isolates identified five different STs: ST1399, ST147, ST29, ST405 and ST340 (Table 2) .
Plasmid studies
No transconjugants were obtained from any of the donors. After electroporation, five transformants expressed bla NDM-1 , three transformants co-expressed bla NDM-1 , bla CTX-M-15 and bla TEM-1 , and two transformant coexpressed bla NDM-1 and bla CTX-M-15 . In addition, two transformants expressed qnrS determinant (Table 2) .
No replicons type could be determined in three of the 10 parental strains tested. An F replicon was detected in five isolates, a Lvpk replicon in two isolates and an A/C replicon in two isolates. In addition to an F replicon, Enterobacter cloacae 18 carried the repA, traU and parA genes (Table 2) .
Among transformants expressing only NDM-1, the FII1K replicon was detected in four transformants from two Enterobacter cloacae and two K. pneumoniae donors. The rest of the transformants were untypable ( (Abdelaziz et al., 2013) . For instance, more than 1.5 million foreign pilgrims from different nations travel to Saudi Arabia during the same period every year to perform Hajj (Memish, 2010) . The Asghar (2006) study showed that septicaemia episodes at hospitals in Makkah increased by 16.5 % in that year during Hajj time due to the influx of international patients.
Our results showed that NDM-producing K. pneumoniae strains belonged to different STs. K. pneumoniae ST147 strains were previously involved in NDM-1 dissemination in Iraq (Poirel et al., 2011b) , Canada (Peirano et al., 2011) , China (Wang et al., 2014) and Australia (Sidjabat et al., 2011) , whilst K. pneumoniae ST340 was observed in carbapenemases producing K. pneumoniae in Israel (Leavitt et al., 2010) , South Korea (Kim et al., 2012) and the Sultanate of Oman (Poirel et al., 2011a) . These clones also produced KPC and CTX-M-15 enzymes. ST405 NDM-1-producing K. pneumoniae isolates were reported in Spain (Oteo et al., 2013) , and ST29 NDM-1-producing K. pneumoniae isolates were described in India (Castanheira et al., 2013) .
In our study, bla NDM-1 genes were located on plasmids carrying the FII1K replicon in four isolates. The IncFII plasmid is known to be a major vehicle for dissemination of the bla CTX-M-15 gene. The endemicity of the bla CTX-M-15 -positive and IncFII plasmid in the Indian subcontinent could have created a favourable context for bla NDM-1 gene dissemination . The other isolates were untypable. Different plasmid incompatibility groups carrying bla NDM-1 genes have been reported, including IncA/C, IncL/M and IncF (containing the FIIk replicon) (Castanheira et al., 2013; Peirano et al., 2014) . Our findings support the suggestion that NDM spread is not related to a single type of plasmid or dominant ST.
The origin of the carbapenemase genes in our strains remains a question. Their Indian subcontinent origin cannot be ruled out because some of the Al-Thawra Hospital staff (e.g. housekeepers, nurses and doctors) were from India. Considering that one of the two NDM-1-producing K. pneumoniae isolates previously identified from Oman could not be traced back to the Indian subcontinent, our study provides an additional clue that the Middle East might also be a reservoir for NDM-1 producers.
In concordance with previous reports, all the NDM-1-producing isolates were resistant to multiple antibiotics, including aminoglycosides, fluoroquinolones and cephalosporins, except for tigecycline and colistin. In our study, NDM-1 was co-expressed with CTX-M-15, SHV and TEM-1 b-lactamases. This is the first report of CTX-M-15 in Yemen. CTX-M-15 is predominant in Saudi Arabia (AlAgamy et al., 2009) , Kuwait (Rotimi et al., 2008) , the United Arab Emirates (Alfaresi et al., 2011) and Oman (Poirel et al., 2011a) . This high prevalence may be due to immigrants from countries with a high rate of CTX-M-15-positive Enterobacteriaceae (Ensor et al., 2009 ). The association of qnrB genes with bla NDM-1 observed in our study was similar to previous reports from Egypt (Abdelaziz et al., 2013) , Morocco (Poirel et al., 2011c) , Australia (Shoma et al., 2014) , Singapore (Teo et al., 2014) , India (Khan & Nordmann; , Belgium (Bogaerts et al., 2011) and France (Arpin et al., 2012) . We also observed the previously described associations between qnrS and bla NDM-1 genes (Peirano et al., 2011; Islam et al., 2012) and bla NDM-1 and qnrA genes in Bangladesh (Islam et al., 2012) .
This study was not based on systematic surveillance of carbapenem resistance and so the sample size was small. However, our findings can form the basis for further investigations of carbapenem-resistant Enterobacteriaceae in Yemen. Awareness of these strains is essential in order to prevent their selection and spread.
Given the reported propensity of this resistance mechanism to disseminate, it seems inevitable that further isolation of NDM-producing organisms will continue to occur in this region. It is therefore imperative that clinicians and laboratories remain vigilant, both in detecting these organisms and in instituting appropriate infection control measures to prevent NDM-producing Enterobacteriaceae from causing further epidemics.
